108 related articles for article (PubMed ID: 94124)
21. [Fibrin and fibrinogen degradation products in head- and neck-tumors (author's transl)].
Wilmes EH; Hochstrasser K
Laryngol Rhinol Otol (Stuttg); 1978 Dec; 57(12):1083-6. PubMed ID: 732487
[TBL] [Abstract][Full Text] [Related]
22. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
Dyr JE; Cajthamlová H; Suttnar J
Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
[TBL] [Abstract][Full Text] [Related]
23. [Characteristics of the coagulative and immunological properties of fibrinogen degradation products].
Fedorova ZD; Paradeeva IK; Zhukova IV; Elizarova AI; Pshenichnaia LN
Probl Gematol Pereliv Krovi; 1980 Jan; 25(1):44-6. PubMed ID: 6768062
[No Abstract] [Full Text] [Related]
24. [Quantitative assay of fibrinogen and fibrin grafts. Simple radial immunodiffusion and electroimmunoassay (author's transl)].
Blatný J; Rozprínová L; Fiserová E; Frágner J
Cas Lek Cesk; 1976 Jul; 115(28):861-4. PubMed ID: 821614
[No Abstract] [Full Text] [Related]
25. A simple and practical method for isolation of an early plasmin degradation product of human fibrinogen.
Takagi K; Kawai T
Thromb Haemost; 1977 Jun; 37(3):464-70. PubMed ID: 142313
[TBL] [Abstract][Full Text] [Related]
26. Fibrinogen degradation products in fresh frozen plasma. Possible contribution to immunosuppression.
Donnell CA; Daniel SJ; Ferrara JJ
Am Surg; 1989 Aug; 55(8):505-7. PubMed ID: 2764399
[TBL] [Abstract][Full Text] [Related]
27. Significance of the quantitative determination of "fibrin degradation products" in renal diseases.
Chin Med J (Engl); 1980 Jul; 93(7):483-6. PubMed ID: 6772396
[No Abstract] [Full Text] [Related]
28. [A comprehensive laboratory evaluation of changes in the fibrinogen molecule in the diagnosis of acquired coagulopathy conditions].
Siatkovskiĭ VA; Azarova LA; Vasilenko PL
Lab Delo; 1989; (8):45-8. PubMed ID: 2477628
[TBL] [Abstract][Full Text] [Related]
29. [Comparative fibrinogen determination by artificial in vitro fibrinogen lysis with regard to fibrinogen split products].
Kätzel R; Brunner HP; Bohr A
Z Med Lab Diagn; 1981; 22(3):138-43. PubMed ID: 7293326
[No Abstract] [Full Text] [Related]
30. Quantitation of the coagulation inhibition in vivo due to breakdown products of fibrin.
Mitchell PS; Beller FK
Thromb Diath Haemorrh; 1970 Jun; 23(3):477-85. PubMed ID: 4989113
[No Abstract] [Full Text] [Related]
31. [Critical evaluation of new methods for studying fibrin degradation products].
Prisco D
Recenti Prog Med; 1989 May; 80(5):263-7. PubMed ID: 2669062
[TBL] [Abstract][Full Text] [Related]
32. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a new anti-fibrinogen-coated latex particle agglutination test in the measurement of serum fibrin degradation products.
Marder VJ; Cruz GO; Schumer BR
Thromb Haemost; 1977 Apr; 37(2):183-91. PubMed ID: 577622
[TBL] [Abstract][Full Text] [Related]
35. [Determination of fibrinogen/fibrin degradation products for diagnostic purposes in internal diseases].
Iwańska J; Donicowa K; Barańska H; Jarczewski J
Pol Tyg Lek; 1977 Jun; 32(26):993-6. PubMed ID: 882451
[No Abstract] [Full Text] [Related]
36. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
Lychev VG; Momot AP; Cherkashin GV
Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
[TBL] [Abstract][Full Text] [Related]
37. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
Koppert PW; Kuipers W; Hoegee-de Nobel B; Brommer EJ; Koopman J; Nieuwenhuizen W
Thromb Haemost; 1987 Feb; 57(1):25-8. PubMed ID: 2438796
[TBL] [Abstract][Full Text] [Related]
38. [Determination of blood fibrinogen (fibrin) degradation products by reaction to hemagglutination delay of sensitized erythrocytes].
Ponizovskiĭ MP; Tsynkalovskaia SN
Vrach Delo; 1976 Aug; (8):115-7. PubMed ID: 1020269
[No Abstract] [Full Text] [Related]
39. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
Feddersen C
Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
[No Abstract] [Full Text] [Related]
40. [Determination of fibrinogen and fibrin degradation products].
Fujimaki M; Ikematsu S
Nihon Rinsho; 1976; 34 suppl():2390-7. PubMed ID: 1033361
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
